Valuation
- Market cap
- 4,000
- Revenue TTM
- $9,510,000
- Net income TTM
- $-7,430,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -78.13%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- 6,486
- Day's range
- $0.00 – $0.00
- Shares out
- 10,225,000
- Stochastic %K
- 1%
- Beta
- 0.62
- Analysts
- —
- Price target
- —
Company profile
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic...
Show more
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 206 734 4738
- Website
- https://www.evbiologics.com
- Address
- 1621 Central Avenue, Cheyenne, United States
Latest news
No headlines yet.
